JP2019516375A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516375A5
JP2019516375A5 JP2018560186A JP2018560186A JP2019516375A5 JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5 JP 2018560186 A JP2018560186 A JP 2018560186A JP 2018560186 A JP2018560186 A JP 2018560186A JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5
Authority
JP
Japan
Prior art keywords
allele
pos
nuclear position
snp
nuclear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560186A
Other languages
English (en)
Japanese (ja)
Other versions
JP7475811B2 (ja
JP2019516375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033625 external-priority patent/WO2017201461A1/en
Publication of JP2019516375A publication Critical patent/JP2019516375A/ja
Publication of JP2019516375A5 publication Critical patent/JP2019516375A5/ja
Priority to JP2022044738A priority Critical patent/JP7392020B2/ja
Priority to JP2023213224A priority patent/JP2024037945A/ja
Application granted granted Critical
Publication of JP7475811B2 publication Critical patent/JP7475811B2/ja
Priority to JP2025203084A priority patent/JP2026048696A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560186A 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断 Active JP7475811B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022044738A JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662339357P 2016-05-20 2016-05-20
US62/339,357 2016-05-20
PCT/US2017/033625 WO2017201461A1 (en) 2016-05-20 2017-05-19 Diagnosis of inflammatory bowel disease based on genes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022044738A Division JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Division JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Publications (3)

Publication Number Publication Date
JP2019516375A JP2019516375A (ja) 2019-06-20
JP2019516375A5 true JP2019516375A5 (enExample) 2020-06-18
JP7475811B2 JP7475811B2 (ja) 2024-04-30

Family

ID=60326226

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018560186A Active JP7475811B2 (ja) 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A Pending JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A Pending JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Country Status (6)

Country Link
US (2) US11549146B2 (enExample)
EP (1) EP3458466B1 (enExample)
JP (4) JP7475811B2 (enExample)
KR (4) KR20230003433A (enExample)
CN (2) CN109476698B (enExample)
WO (1) WO2017201461A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
KR20180127416A (ko) 2016-03-17 2018-11-28 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법
CN109476698B (zh) * 2016-05-20 2023-10-17 西达-赛奈医疗中心 基于基因的炎性肠病诊断
CA3121162A1 (en) 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Rnaset2 compositions and methods of treatment therewith
CN114375339A (zh) 2019-05-14 2022-04-19 普罗米修斯生物科学公司 Tl1a患者选择方法、系统和装置
CN116322762A (zh) * 2020-06-26 2023-06-23 辉瑞公司 用tl1a抗体治疗炎症性肠病的方法
JP2023551602A (ja) * 2020-11-13 2023-12-08 プロメテウス バイオサイエンシーズ，インク． Ｔｌ１ａを標的とする炎症性疾患の治療のための方法、システム、およびキット
CN115851911B (zh) * 2022-11-25 2025-10-24 南京鼓楼医院 一种用于鉴别狼疮性肾炎的尿液外泌体tsRNA标志物和探针及其应用
EP4646434A2 (en) * 2023-01-06 2025-11-12 Prometheus Biosciences, Inc. Methods of treating inflammatory diseases with combination of tl1a inhibitors and tnf inhibitors
IL325993A (en) 2023-08-11 2026-03-01 Paragon Therapeutics Inc TL1A binding proteins and methods of use

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443421A (en) 1982-03-16 1984-04-17 Occidental Chemical Corporation Process for removing particulate impurities from aqueous phosphoric acid
DE3475880D1 (en) 1984-08-27 1989-02-09 Toray Industries Solid-liquid separating apparatus
US5000850A (en) 1986-09-10 1991-03-19 Engelhard Corporation Apparatus for dewatering an aqueous clay suspension
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
JP2002521062A (ja) * 1998-07-25 2002-07-16 アストラゼネカ・アクチエボラーグ ヒトニューロキニン１レセプター遺伝子における遺伝子多形性および疾病の診断および処置におけるその使用
JP2004194534A (ja) 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
CN1890384A (zh) * 2003-10-06 2007-01-03 诺瓦提斯公司 与炎性疾病的治疗功效相关的遗传多态性的用途
US20060134663A1 (en) 2004-11-03 2006-06-22 Paul Harkin Transcriptome microarray technology and methods of using the same
BRPI0611069A2 (pt) 2005-05-06 2010-11-09 Zymogenetics Inc anticorpo monoclonal, anticorpo humanizado, fragmento de anticorpo, uso de um antagonista, e, hibridoma
WO2006127900A2 (en) 2005-05-25 2006-11-30 Biogen Idec Ma Inc. Tl1a in the treatment of disease
CA2634146A1 (en) * 2005-12-19 2007-06-28 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
US20090018031A1 (en) 2006-12-07 2009-01-15 Switchgear Genomics Transcriptional regulatory elements of biological pathways tools, and methods
US20110217310A1 (en) * 2007-01-10 2011-09-08 Siegel Richard M Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
US20100190162A1 (en) * 2007-02-26 2010-07-29 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
US20100055700A1 (en) 2007-02-28 2010-03-04 Cedars-Sinai Medical Center Role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
WO2011088380A1 (en) * 2010-01-15 2011-07-21 Cedars-Sinai Medical Center Methods of using fut2 genetic variants to diagnose crohn's disease
US20150376707A1 (en) * 2007-05-18 2015-12-31 Cedars-Sinai Medical Center Methods of diagnosing and treating inflammatory bowel disease
US8118175B2 (en) 2007-07-18 2012-02-21 Siemens Industry, Inc. Venting device for a disc filter
WO2009039244A2 (en) * 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
WO2009052512A2 (en) * 2007-10-19 2009-04-23 Cedars-Sinai Medical Center Methods of using genetic variants to diagnose and predict inflammatory bowel disease
MX2010005282A (es) 2007-11-13 2010-08-31 Teva Pharma Anticuerpos humanizados contra tl1a.
PE20110565A1 (es) * 2008-08-12 2011-09-02 Zinfandel Pharmaceuticals Inc Metodo de identificacion de factores de riesgo de la enfermedad
WO2010025340A2 (en) 2008-08-29 2010-03-04 Centocor Ortho Biotech Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
JP2010088432A (ja) 2008-09-09 2010-04-22 Kansetsu Saisei Kenkyusho:Kk Ｔｎｆ阻害薬治療による有効性・副作用発現に関する多型、およびその利用
WO2010062960A2 (en) * 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
WO2010075579A2 (en) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
NZ595471A (en) 2009-04-14 2014-01-31 Nestec Sa Inflammatory bowel disease prognostics
JP2013528389A (ja) * 2010-06-04 2013-07-11 ネステク ソシエテ アノニム 炎症性腸疾患の診断を改善させる方法
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
AU2011325956B2 (en) 2010-11-12 2016-07-14 The General Hospital Corporation Polycomb-associated non-coding RNAs
US9902996B2 (en) * 2011-02-11 2018-02-27 Cedars-Sinai Medical Center Methods of predicting the need for surgery in crohn's disease
WO2012154987A1 (en) 2011-05-10 2012-11-15 Nestec Sa Methods of disease activity profiling for personalized therapy management
WO2012156515A1 (en) 2011-05-18 2012-11-22 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
AU2012259312A1 (en) 2011-05-20 2013-12-12 Government Of The United States, As Represented By The Secretary Department Of Health And Human Services Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
PH12013502489B1 (en) 2011-06-03 2019-04-24 Xoma Technology Ltd Antibodies specific for tgf-beta
EP2769321B1 (en) 2011-10-21 2016-06-01 Nestec S.A. Methods for improving inflammatory bowel disease diagnosis
KR20140124767A (ko) * 2012-02-10 2014-10-27 노보 노르디스크 에이/에스 염증성 질환 및 장애의 치료에 관한 방법
KR20230109779A (ko) 2013-03-27 2023-07-20 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전
CN105358713B (zh) * 2013-05-17 2020-02-28 雪松-西奈医学中心 与克罗恩病相关的tnfsf15和dcr3的变体
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
US11365447B2 (en) * 2014-03-13 2022-06-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20180305689A1 (en) 2015-04-22 2018-10-25 Mina Therapeutics Limited Sarna compositions and methods of use
TWI737685B (zh) 2016-02-26 2021-09-01 美商奈米科技能源公司 用於處理含碳組合物之方法、裝置及系統
CN109476698B (zh) 2016-05-20 2023-10-17 西达-赛奈医疗中心 基于基因的炎性肠病诊断
WO2018022982A1 (en) 2016-07-29 2018-02-01 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
CN118240830A (zh) 2016-10-26 2024-06-25 西达-赛奈医疗中心 中和抗tl1a单克隆抗体
US20210254056A1 (en) 2017-05-05 2021-08-19 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
WO2020121618A1 (ja) 2018-12-14 2020-06-18 株式会社フジクラ フェルール、ファイバ付きフェルール及びファイバ付きフェルールの製造方法

Similar Documents

Publication Publication Date Title
JP2012080900A5 (enExample)
JP2012503985A5 (enExample)
JP2018038436A5 (enExample)
WO2007130519A3 (en) Viral nucleic acid microarray and method of use
JP2009528060A5 (enExample)
JP2016041070A5 (enExample)
JP2017507130A5 (enExample)
CA2938731A1 (en) Methods of treating alzheimer's disease
JP2010529857A5 (enExample)
JP2013532494A5 (enExample)
JP2014533949A5 (enExample)
JP2011528903A5 (enExample)
JP2010528590A5 (enExample)
JP2013544536A5 (enExample)
JP2021511075A (ja) 癌におけるマイクロサテライト不安定性を検出するためのバイオマーカーパネル及び方法
US20150011415A1 (en) Method for calculating a disease risk score
JP2009526524A5 (enExample)
Schorderet et al. IROme, a New High‐Throughput Molecular Tool for the Diagnosis of Inherited Retinal Dystrophies
AU2015213570B2 (en) NGS systems control and methods involving the same
JP2011530312A5 (enExample)
JP2011502510A5 (enExample)
JP2013074888A (ja) ＩＬ２８Ｂ（ｒｓ８０９９９１７）とＩＴＰＡ（ｒｓ１１２７３５４）の変異を検出する方法
KR101287431B1 (ko) 표적 유전자의 다양한 변이가 존재하는 유전자 영역을 증폭하기 위한 프라이머 조성물, 이를 이용한 표적 유전자 증폭 방법 및 이를 포함하는 ｐｃｒ 증폭 키트 그리고 이를 이용한 표적 유전자의 유전자형 분석방법
Niihara et al. Simple and rapid detection of HLA-A* 31: 01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method
Papanikos et al. Lateral flow dipstick test for genotyping of 15 beta-globin gene (HBB) mutations with naked-eye detection